RWM.F

Healthcare Drug Manufacturers - Specialty & Generic

Rockwell Medical, Inc.

€0.45
-4.80 -91.37% today

Price History

Not enough data

Key Stats

Market Cap
1.83M
Avg Volume
0
EPS
-€1.15
52W High
€10.48
52W Low
€0.45
Div. Yield
0.0%

Valuation

P/B Ratio
0.06
P/S Ratio
0.03
EV/EBITDA
3.72
EV/Revenue
-0.13
PEG Ratio
4.19

Margins

Gross Margin 17.7%
Operating Margin (6.0%)
Net Margin (7.3%)
EBITDA Margin (3.5%)

Growth & Returns

Revenue Growth (YoY)
10.6%
Return on Equity
(15.5%)
Return on Assets
(5.2%)

Liquidity & Leverage

Current Ratio
3.25
Quick Ratio
2.96
Debt / Equity
0.40
Total Cash
24.80M
Total Debt
13.93M

About

Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. In addition, it offers dialysis concentrates, dialysis kits, and other ancillary products used in the dialysis process. The company was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

www.rockwellmed.com